http://www.evrs.eu/medias/2006/congress/AMD,-Hypertension-and-Potential-Cardiovascular-Risks-with-Intravitreal-Avastin-Injection.swf

Claude Boscher, MD (Paris, France), Maryam Amini, MD (Paris, France), Béryl Cathelineau, MD (Paris, France), Philippe Verdy,  MD (Paris, France), Florence Coscas, MD (Paris, France), Olivier LaPlace, MD (Paris, France), Kathy Perlemuter, MD (Paris, France), Jean Pierre Usdin, MD (Paris, France)

PURPOSE:

Signs of hypertensive retinopathy have been recently correlated with microcerebral infarcts on MRI, risks of stroke, and congestive heart failure. The purpose of this study is to reconsider association between AMD and signs of hypertensive retinopathy at fundus examination.

METHODS:

Retrospective study of consecutive patients with AMD and associated signs of chronic hypertensive retinopathy at fundus examination, and recommendation of cardiovascular (re)examination and /or 24 hours blood pressure ambulatory monitoring.

RESULTS:

Unrecognized or insufficiently treated high blood pressure has been detected in 32/61 patients (52%).

CONCLUSION:

To detect associated hypertensive retinopathy in cases of AMD might be useful: 1) to help the cure of the disease; 2) to detect  cardiovascular risks before intravitreal Avastin injection; 3) to protect the fellow eye.